Wang Xuefei, Chai Yemao, Dou Ye, Li Xinyi, Li Fanghe, Gao Kuo
Beijing University of Chinese Medicine, Beijing, China.
Front Immunol. 2025 Mar 5;16:1501432. doi: 10.3389/fimmu.2025.1501432. eCollection 2025.
Hypertension continues to be a global health and economic burden, conventionally characterized by a chronic inflammatory state. Macrophages are critical for the initiation, progression and manifestation of hypertension. As studies on the relationship between macrophages and hypertension increase substantially, identifying critical research areas and unraveling potential interaction mechanisms become increasingly essential.
Articles associated with hypertension and macrophages in recent 10 years were retrieved from the Web of Science Core Collection for analysis, using Microsoft Excel, VOSviewer, CiteSpace and Scimago Graphica.
After excluding studies that did not meet inclusive standard based on time (2015-2024) and type (article or reviews), 2,013 original articles related to macrophages associated with hypertension were included. The number of publications has been increasing annually. These records consisted of 2,013 English language papers published in 351 journals by 315 institutions or regions from 83 countries/regions between 2015 and 2024. We analyzed the co-cited references clusters to objectively outline the current state of research, including the regulatory mechanisms of hypertension, diseases related to hypertension, and the lifestyle factor. Inflammation remains one of the most popular research hot-spot. The most popular publishing journal in this field is PLOS ONE and the most prolific writer is Li, Hui-Hua. The primary keywords cluster in this field is inflammation, with the highest occurrences and TLS among the top 10 keywords.
These comprehensive and visualized bibliometric results summarized the significant findings in macrophage-related hypertension studies over the past 10 years. Macrophages appear to be effective in the treatment of hypertension as potential targets, but further research is needed to clarify the specific pathophysiological mechanisms involved.
高血压仍然是一个全球性的健康和经济负担,传统上以慢性炎症状态为特征。巨噬细胞对高血压的发生、发展和表现至关重要。随着关于巨噬细胞与高血压之间关系的研究大幅增加,确定关键研究领域并阐明潜在的相互作用机制变得越来越重要。
从Web of Science核心合集检索近10年与高血压和巨噬细胞相关的文章,使用Microsoft Excel、VOSviewer、CiteSpace和Scimago Graphica进行分析。
在排除不符合基于时间(2015 - 2024年)和类型(文章或综述)的纳入标准的研究后,纳入了2013篇与巨噬细胞相关的高血压原始文章。出版物数量逐年增加。这些记录包括2015年至2024年间由来自83个国家/地区的315个机构或地区在351种期刊上发表的2013篇英文论文。我们分析了共被引参考文献聚类,以客观概述当前的研究状况,包括高血压的调节机制、与高血压相关的疾病以及生活方式因素。炎症仍然是最热门的研究热点之一。该领域最受欢迎的出版期刊是《PLOS ONE》,最多产的作者是李惠华。该领域的主要关键词聚类是炎症,在前10个关键词中出现次数和TLS最高。
这些全面且可视化的文献计量学结果总结了过去10年巨噬细胞相关高血压研究的重要发现。巨噬细胞作为潜在靶点似乎在高血压治疗中有效,但需要进一步研究以阐明其中涉及的具体病理生理机制。